Drug Database
Back to search

Germany· DE-A57-6c402e016092251d

Ciclocutan

A ciclopirox product containing ciclopirox, registered in Germany by Dermapharm Ag. The same ATC class is registered in 12 of our 19 countries.

ATC D01AE14

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedCiclocutanATCD01AE14REGISTER NO.DE-A57-6c402e01609225…PACKS LISTED0CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ciclopiroxAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ciclopirox is registered in 12 of 19 countries.

Countries holding a registration under ATC D01AE14 (ciclopirox), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 7 of them publish a price we can compare per daily dose
Search ciclopirox products by name

Ciclopirox · ATC D01AE14

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ciclopirox costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from <$0.001 in Czechia to $2.04 in Switzerland — a ×4085 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Ciclopirox · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.04
  • CZ Czechia<$0.001
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)
Active substance
Ciclopirox
Manufacturer
Dermapharm Ag
Country
Germany (DE)
ATC code
D01AE14
ATC class
Ciclopirox
Defined daily dose
20 mg, T
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

118 interactions on record for ciclopirox.

Graded by severity as the source publishes them — 118 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ciclopirox against other medicinesHow interaction checks work

Ciclopirox · interactions on record

118 records

  • 118 info

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Ciclopirox in 13 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All ciclopirox products

    Authorised across Europe · EMA

    The same active substance is authorised in 26 EEA countries. Names it is sold under:

    • Austria · Ciclocutan, Kitonail
    • Belgium · Myconail, Mycosten
    • Bulgaria · Батрафен, Микодефен
    • Cyprus · Kitonail, Mycomycen
    • Czechia · Polinail
    • Denmark · Onytec
    • Estonia · Ciclopirox Auxilia
    • Spain · Ciclochem Uñas, Ciclocutan
    • Finland · Onytec
    • France · Ciclopirox Biogaran, Ciclopirox Substipharm
    • United Kingdom (Northern Ireland) · Onytec
    • Greece · Mycomycen
    • Croatia · Oxolam
    • Hungary · Batrafen, Kitolak
    • Ireland · Onytec
    • Italy · Carediesse, Niogermox
    • Lithuania · Onytec
    • Luxembourg · Mycoster
    • Latvia · Onytec
    • Norway · Onytec
    • Poland · Axopirox, Ciclolack
    • Portugal · Dexulac, Mycoster
    • Romania · Kitonail
    • Sweden · Onytec
    • Slovenia · Onytec
    • Slovakia · Polinaill

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/93ada972-686b-42b9-a1b2-084df8769887
GET /v1/drugs/93ada972-686b-42b9-a1b2-084df8769887?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "pzn": null,
  "route": "Cutaneous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Ciclopirox",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
    API referenceMCP serverPlans

    See everything about ciclopirox.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console